Skye Bioscience Statistics
NASDAQ: SKYEHealthcareBiotechnologyUSD
1.68+0.03 (+1.82%)
At close: Oct 8, 4:00 PM ET · Delayed 15 min
Skye Bioscience by the numbers
Skye Bioscience has a market capitalization of $7.4 million based on 4.43M shares outstanding. With trailing EPS of $-10.16, Skye Bioscience is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 32.8% below its 50-day average and 68.4% below its 200-day average.
Average daily trading volume is 89.28K shares, or about $149,994 in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
SKYE valuation vs. peer median
| Metric | SKYE | Peer median | Difference |
|---|---|---|---|
| Market cap | $7.44M | $7.42M | +0% |
| Avg. volume | 89.28K | 266.94K | -67% |
Peer median across 8 companies: TRAW, AIM, CURX, CLGN, SNGX, LGVN, BOLT, APRE.
Valuation
- Market cap
- $7.44M
- EPS (TTM)
- $-10.16
- Shares outstanding
- 4.43M
Price and trading
- Previous close
- 1.65
- Open
- 1.66
- Day range
- 1.63 – 1.68
- 52-week range
- 1.50 – 14.08
- Beta
- —
- Volume
- 20.86K
- Average volume
- 89.28K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 9, 2026
Additional statistics
- Market Cap
- 7.44M
- Forward Pe
- -0.23
- Eps
- -10.16
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 14.08
- Week52 Low
- 1.50
- Avg Volume
- 89,282.00
- Shares Outstanding
- 4.43M
- Ma50
- 2.50
- Ma200
- 5.32
- Earnings Date
- Nov 9, 2026
- Pct From52w High
- -88.07%
- Pct From52w Low
- 12.00%